Guangdong Marubi Biotechnology Co Ltd
SSE:603983
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (43.5), the stock would be worth ¥37.59 (49% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 29.1 | ¥25.17 |
0%
|
| 3-Year Average | 43.5 | ¥37.59 |
+49%
|
| 5-Year Average | 45.5 | ¥39.33 |
+56%
|
| Industry Average | 22.4 | ¥19.34 |
-23%
|
| Country Average | 29.6 | ¥25.62 |
+2%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥12.2B
|
/ |
Oct 2025
¥346.7m
|
= |
|
|
¥12.2B
|
/ |
Dec 2025
¥393.2m
|
= |
|
|
¥12.2B
|
/ |
Dec 2026
¥424m
|
= |
|
|
¥12.2B
|
/ |
Dec 2027
¥502.2m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
G
|
Guangdong Marubi Biotechnology Co Ltd
SSE:603983
|
10.1B CNY | 29.1 | |
| FR |
|
L'Oreal SA
PAR:OR
|
195.4B EUR | 31.9 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.7B GBP | 11.6 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 36.4 | |
| UK |
|
HALEON PLC
LSE:HLN
|
30.3B GBP | 18.2 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
27.7B USD | -155.9 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
15.5B EUR | 16.5 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 22.1 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 59.9 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -4 624.4 | |
| IN |
|
Dabur India Ltd
NSE:DABUR
|
783.1B INR | 42.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
Guangdong Marubi Biotechnology Co Ltd
Glance View
Guangdong Marubi Biotechnology Co Ltd stands as a compelling narrative of innovation and heritage in the realm of beauty and skincare. Established in 2002, the company has carved a niche in China’s competitive cosmetics industry by blending advanced biotechnology with traditional skincare practices. This fusion forms the backbone of Marubi’s product portfolio, which spans an array of skincare solutions including anti-aging serums, hydrating masks, and rejuvenating creams. The company’s strength lies in its robust research and development framework, where scientific rigor meets the potential of natural ingredients, leading to the formulation of effective skincare products. By fostering partnerships with renowned research institutions, Marubi ensures that its offerings are not only well-aligned with consumer expectations but also backed by solid scientific evidence. In the financial landscape, Marubi’s operational model is keenly focused on understanding consumer trends and leveraging digital marketing strategies to solidify its market position. A significant portion of the company’s revenues is generated through e-commerce platforms, which tap into China’s rapidly growing online retail market. Emphasizing brand loyalty and customer engagement, Marubi has utilized social media and collaborations with influencers to promote its products and extend its reach beyond traditional retail channels. Moreover, the company has established a keen presence in offline sales, ensuring its brand stands out in both bustling urban centers and emerging local markets. Through this strategic synergy between online and offline sales avenues, Guangdong Marubi Biotechnology Co Ltd thrives as a modern skincare powerhouse, creating value continuously in an ever-evolving market landscape.